ATE483021T1 - Protein, das mit einem neuroendokrinspezifischen protein änhelt, und dafür kodierende cdns - Google Patents

Protein, das mit einem neuroendokrinspezifischen protein änhelt, und dafür kodierende cdns

Info

Publication number
ATE483021T1
ATE483021T1 AT99934913T AT99934913T ATE483021T1 AT E483021 T1 ATE483021 T1 AT E483021T1 AT 99934913 T AT99934913 T AT 99934913T AT 99934913 T AT99934913 T AT 99934913T AT E483021 T1 ATE483021 T1 AT E483021T1
Authority
AT
Austria
Prior art keywords
protein
cdns
neuroendocrine
coding therefor
similar
Prior art date
Application number
AT99934913T
Other languages
English (en)
Inventor
David Michalovich
Rabinder Kumar Prinjha
Original Assignee
Smithkline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26314097&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE483021(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9816024.5A external-priority patent/GB9816024D0/en
Priority claimed from GBGB9916898.1A external-priority patent/GB9916898D0/en
Application filed by Smithkline Beecham Ltd filed Critical Smithkline Beecham Ltd
Application granted granted Critical
Publication of ATE483021T1 publication Critical patent/ATE483021T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2497—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing N- glycosyl compounds (3.2.2)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
AT99934913T 1998-07-22 1999-07-21 Protein, das mit einem neuroendokrinspezifischen protein änhelt, und dafür kodierende cdns ATE483021T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9816024.5A GB9816024D0 (en) 1998-07-22 1998-07-22 Novel compounds
GBGB9916898.1A GB9916898D0 (en) 1999-07-19 1999-07-19 Novel compounds
PCT/GB1999/002360 WO2000005364A1 (en) 1998-07-22 1999-07-21 Protein similar to neuroendrocrine-specific protein, and encoding cdna

Publications (1)

Publication Number Publication Date
ATE483021T1 true ATE483021T1 (de) 2010-10-15

Family

ID=26314097

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99934913T ATE483021T1 (de) 1998-07-22 1999-07-21 Protein, das mit einem neuroendokrinspezifischen protein änhelt, und dafür kodierende cdns

Country Status (9)

Country Link
US (4) US20020010324A1 (de)
EP (2) EP2264174A3 (de)
JP (1) JP2002522016A (de)
AT (1) ATE483021T1 (de)
CY (1) CY1110961T1 (de)
DE (1) DE69942803D1 (de)
DK (1) DK1098972T3 (de)
PT (1) PT1098972E (de)
WO (1) WO2000005364A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2264174A3 (de) * 1998-07-22 2012-03-07 SmithKline Beecham Limited Protein, das mit einem Neuroendokrinspezifischen Protein änhelt, und dafür kodierende cDNS
CZ304224B6 (cs) * 1998-11-06 2014-01-15 Schwab Monoklonální protilátka
US7186530B1 (en) 2000-04-07 2007-03-06 Chiron Corporation Protein associated with cell stress response
WO2000060083A1 (en) * 1999-04-08 2000-10-12 Chiron Corporation Novel protein associated with cell stress response
US6566372B1 (en) * 1999-08-27 2003-05-20 Ligand Pharmaceuticals Incorporated Bicyclic androgen and progesterone receptor modulator compounds and methods
US7119165B2 (en) 2000-01-12 2006-10-10 Yale University Nogo receptor-mediated blockade of axonal growth
US20030124704A1 (en) 2000-10-06 2003-07-03 Strittmatter Stephen M. Nogo receptor homologs
AR040778A1 (es) 2002-08-06 2005-04-20 Glaxo Group Ltd Anticuerpos alterados o fragmentos funcionales que se unen a mag (glicoproteina asociada a mielina).
GB0228832D0 (en) 2002-12-10 2003-01-15 Novartis Ag Organic compound
US20060122110A1 (en) 2002-12-06 2006-06-08 Zhi-Cheng Xiao Nogo, caspr, f3 nb-3 useful in the treatment of injury and disease to the central nervous system
GB0306309D0 (en) 2003-03-19 2003-04-23 Glaxo Group Ltd Method of treatment
GB0321997D0 (en) * 2003-09-19 2003-10-22 Novartis Ag Organic compound
EP1904091A4 (de) 2005-07-07 2009-12-23 Univ Yale Zusammensetzungen und verfahren zur unterdrückung der axonalen wachstumshemmung
EP1952147A2 (de) 2005-11-16 2008-08-06 Novartis AG Biomarker zur anti-nogo-a-antikörperbehandlung bei rückenmarksverletzung
GB0525662D0 (en) 2005-12-16 2006-01-25 Glaxo Group Ltd Immunoglobulins
CN111743999A (zh) * 2013-10-09 2020-10-09 味之素株式会社 抗疲劳组合物

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0232262A4 (de) 1985-08-15 1989-09-19 Stauffer Chemical Co Tryptophan erzeugender mikroorganismus.
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
CA1341050C (en) * 1988-11-04 2000-07-11 Martin E. Schwab Neurite growth regulatory factors
US5858708A (en) * 1996-08-12 1999-01-12 Bandman; Olga Polynucleotides encoding two novel human neuroendocrine-specific proteins
CA2269755A1 (en) * 1996-10-25 1998-04-30 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
US20070224663A1 (en) * 1997-03-07 2007-09-27 Human Genome Sciences, Inc. Human Secreted Proteins
WO1998045437A2 (en) * 1997-04-10 1998-10-15 Genetics Institute, Inc. SECRETED EXPRESSED SEQUENCE TAGS (sESTs)
JP2001519666A (ja) * 1997-04-10 2001-10-23 ジェネティックス・インスチチュート・インコーポレーテッド 分泌発現配列タグ（ｓＥＳＴｓ）
CA2294526A1 (en) * 1997-06-13 1998-12-17 Human Genome Sciences, Inc. 86 human secreted proteins
US6222029B1 (en) * 1997-08-01 2001-04-24 Genset 5′ ESTs for secreted proteins expressed in brain
PT1000146E (pt) * 1997-08-01 2006-10-31 Serono Genetics Inst Sa Ests 5' para proteinas secretadas sem especificidade tecidular
DE69841110D1 (de) * 1997-12-17 2009-10-08 Serono Genetics Inst Sa Verlängerte cdns, die für sekretierte proteine kodieren
WO1999033979A2 (en) * 1997-12-30 1999-07-08 Chiron Corporation Bone marrow secreted proteins and polynucleotides
US20020072493A1 (en) * 1998-05-19 2002-06-13 Yeda Research And Development Co. Ltd. Activated T cells, nervous system-specific antigens and their uses
EP2264174A3 (de) * 1998-07-22 2012-03-07 SmithKline Beecham Limited Protein, das mit einem Neuroendokrinspezifischen Protein änhelt, und dafür kodierende cDNS
CZ304224B6 (cs) * 1998-11-06 2014-01-15 Schwab Monoklonální protilátka
US7119165B2 (en) * 2000-01-12 2006-10-10 Yale University Nogo receptor-mediated blockade of axonal growth
EP1177859B1 (de) * 2000-07-31 2009-04-15 Ebara Corporation Substrathalter und Poliervorrichtung

Also Published As

Publication number Publication date
WO2000005364A1 (en) 2000-02-03
EP2264174A3 (de) 2012-03-07
DK1098972T3 (da) 2011-01-03
US20090192294A1 (en) 2009-07-30
EP1098972A1 (de) 2001-05-16
DE69942803D1 (de) 2010-11-11
CY1110961T1 (el) 2015-06-11
US20020010324A1 (en) 2002-01-24
JP2002522016A (ja) 2002-07-23
EP2264174A2 (de) 2010-12-22
US20130196412A1 (en) 2013-08-01
US20070059721A1 (en) 2007-03-15
PT1098972E (pt) 2010-12-14
EP1098972B1 (de) 2010-09-29

Similar Documents

Publication Publication Date Title
ATE483021T1 (de) Protein, das mit einem neuroendokrinspezifischen protein änhelt, und dafür kodierende cdns
ATE311457T1 (de) Basb029 polynucleotide und polypeptide aus neisseria meningitis
EP0911399A3 (de) HTHBZ47, ein Kringle verwandter Klon
DE69928925D1 (de) Antigene polypeptide aus neisseria meningitidis, dafür kodierende polynukleotide und entsprechende schützende antikörper
EP0879888A3 (de) Patched-2 Polypeptide und Polynucleotide und Methoden zu ihrer Herstellung
EP0943684A3 (de) Frizzled-ähnliche Polypeptide und Polynukleotide
DE69836333D1 (de) Neisseria lactoferrin-bindendes protein
DE60043499D1 (de) Antigene polypeptide aus neisseria meningitidis, dafür kodierende polynukleotide und entsprechende schützende antikörper
ATE281524T1 (de) Moraxella catarrhalis pilq proteine
EP0887416A3 (de) Menschliches AFC1 Enzym
WO2001004141A3 (de) Seripancrin
ATE397069T1 (de) Basb205 polypeptide und dafür kodierende polynukleotide
EP0890646A3 (de) Serine-Protease HE2NW40
WO1999011783A3 (en) T-box polypeptides
EP0887415A3 (de) Menschliches RCE1
ATE312922T1 (de) Moraxella catarrhalis polynukleotide und polypeptide
WO1999038885A3 (en) Sbsemvl polypeptides, being members of the semaphorin protein family, and polynucleotides encoding the same
ATE329025T1 (de) Mfq-111, ein menschliches gtpase-ähnlichers protein
DE60123754D1 (en) Neuer transkriptionsfaktor carp-2
WO1999042580A8 (en) Gaba receptors and their uses
EP0875570A3 (de) Neurodegenerative Polypeptide HHPDZ65
EP0939123A3 (de) Mit den Östrogenrezeptor verwandten Polypeptid SBPERR4
ATE420962T1 (de) Rekombinante n-proteinase, deren herstellung, methoden und anwendungen
DK1266008T3 (da) Akut neuroninduceret calciumbindende protein type 1-ligand
WO1999052944A8 (en) G-protein coupled receptors

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1098972

Country of ref document: EP